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Abstract
Detection and analysis of volatile compounds in exhaled breath represents an attractive tool for monitoring the metabolic 
status of a patient and disease diagnosis, since it is non-invasive and fast. Numerous studies have already demonstrated the 
benefit of breath analysis in clinical settings/applications and encouraged multidisciplinary research to reveal new insights 
regarding the origins, pathways, and pathophysiological roles of breath components. Many breath analysis methods are 
currently available to help explore these directions, ranging from mass spectrometry to laser-based spectroscopy and sen-
sor arrays. This review presents an update of the current status of optical methods, using near and mid-infrared sources, 
for clinical breath gas analysis over the last decade and describes recent technological developments and their applications. 
The review includes: tunable diode laser absorption spectroscopy, cavity ring-down spectroscopy, integrated cavity output 
spectroscopy, cavity-enhanced absorption spectroscopy, photoacoustic spectroscopy, quartz-enhanced photoacoustic spec-
troscopy, and optical frequency comb spectroscopy. A SWOT analysis (strengths, weaknesses, opportunities, and threats) 
is presented that describes the laser-based techniques within the clinical framework of breath research and their appealing 
features for clinical use.
1 Introduction
Humans exhale hundreds of gases, including inorganic 
compounds (e.g., ammonia, nitric oxide, and hydrogen 
sulfide) and volatile organic compounds (VOCs), arising 
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from normal body metabolism [1–4]. Human breath also 
contains exogenous compounds that originate from food 
and beverages or from current or previous environmental 
exposures [5]. Endogenous emissions reflect the changes in 
the internal metabolism when illness occur but can also vary 
in response to various (external) stimuli [6, 7]. Since the 
time of Hippocrates, some diseases have been recognized 
by their associated odor [8]. After Pauling’s breakthrough in 
1971 [9], modern breath analysis has connected these odors 
with specific gas analytes (biomarkers) or a profile of VOCs. 
Although many exhaled compounds potentially reflect the 
physiological and pathophysiological conditions related to 
various diseases, only some VOCs have been established as 
biomarkers [10].
Several methods are currently employed for exhaled vola-
tiles detection, among which mass spectrometry (e.g., gas 
chromatography mass spectrometry, GC-MS) is the most 
widely used analytical tool [11–14]. However, the GC-MS-
based instruments are limited to laboratory settings, do not 
allow online sampling (i.e., exhaling directly into the instru-
ment, usually using an inbuilt system or an external breath 
sampler for feedback exhaled airflow control, including 
a flowmeter) and have a relatively long analysis time (in 
the order of tens of minutes). For these reasons, extensive 
research has been conducted to develop alternate methods 
that can be used to perform rapid, sensitive, online analysis 
in a clinical setting, preferably for many volatile compounds 
simultaneously. Proton-transfer reaction mass spectrometry 
(PTR-MS) [15], selected ion flow-tube mass spectrom-
etry (SIFT-MS) [16], gas chromatography combined with 
ion mobility spectrometry (GC-IMS) [17], and secondary 
electro-spray ionization mass spectrometry (SESI-MS) 
[18] are a few examples of online mass-spectrometric (MS) 
methods currently employed in breath analysis. In spite of 
these advances, there is a continuous need for miniaturized 
devices, in addition to the consideration of an affordable, 
accurate, and user-friendly instrument that should provide 
fast response, preferably in real time.
Compared to online mass spectrometry, laser-based spec-
troscopy can provide an accurate and precise quantitative 
analysis result, with an instrument that does not necessarily 
require an expert user. There are already a few optical breath 
analyzers commercially available for monitoring different 
biomarkers in clinical applications, e.g., non-dispersive 
infrared (NDIR) spectrometers for capnography and for 
measuring 13C in breath to diagnose Helicobacter pylori 
(the bacterium that generates gastric ulcers and gastric can-
cers) [19], an infrared spectrometer for monitoring of  CH4 in 
breath accompanied by electrochemical sensors to detect  H2 
and  O2 for diagnosis of gastrointestinal disorders [20], and a 
cavity ring-down spectroscopy system for detection of breath 
acetone which correlates with abnormal metabolic status, 
such as diabetes [21]. These successful implementations 
of optical breath analyzers in real-life clinical applications 
show the bright future of these systems, especially those 
using lasers as light sources.
Laser spectroscopy can provide real-time (sub-second 
time resolution and breath-cycle resolved) detection of a 
single or several volatile compounds, with detection limits 
ranging from the part-per-million (ppm, µmol /mol) to less 
than part-per-billion (ppb, nmol /mol). Fast online sampling, 
combined with real-time detection, eliminates the need for 
collection and storage, which constituted a potential source 
of errors because of the risk for contamination and dilution 
of the breath sample. Furthermore, breath-cycle resolved 
sampling adds significant advantages such as, resolving the 
different respiratory phases and continuous measurements 
of the volatiles/biomarkers present in these different phases, 
and the possibility to couple and validate physiological and 
gas exchange models. The high precision, absolute accuracy, 
and breath-cycle resolved sampling allow much more data 
to be collected and very detailed biomarker studies to be 
performed. Hence, small differences can be resolved and 
gas exchange processes in the respiratory tract can be char-
acterized, allowing us to gain a better understanding of the 
origin and chemical pathways of the (potential) biomark-
ers. This, in turn, provides a clearer picture about which 
biomarkers really correlate with diseases, which has been 
(and still is) one of the main difficulties researchers face in 
the field of breath research. On the other hand, the future of 
breath analysis could lie in monitoring changes in biomarker 
concentrations compared to control or baseline values, espe-
cially to determine the specific response to interventions, 
such as a pathogen attack, drug treatment, or the intake of 
isotope-labeled substances.
In general, a detection limit of 100 ppt can be considered 
sufficient for almost any breath analysis application. The 
ambient levels of most VOCs will be higher than this con-
centration, and analyzing lower concentrations from exhaled 
breath has questionable utility. There have been several 
approaches proposed to correct for the ambient background 
contribution in breath measurements [22], but none of these 
are entirely reliable. If the concentration of the target species 
in breath is high (as, for e.g., acetone, isoprene, ammonia, 
methane, and carbon monoxide), a more modest detection 
limit is obviously adequate. For real-time measurements, an 
acquisition rate between 1 and 10 Hz should be satisfactory 
in all cases. This will allow a complete characterization of 
individual breath cycles and resolve any disparity between 
the analyte behavior and a standard capnogram (representa-
tion of the partial pressure of  CO2 versus time).
Several reviews covering laser spectroscopic tech-
niques for breath gas analysis are available in the litera-
ture [22–26]. Together, these reviews provide a compre-
hensive overview of near-infrared (near-IR) and mid-IR 
laser-based breath analyzers using various spectroscopic 
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methods, their challenges, and perspectives. Lourenco and 
Turner compare laser-based methods with other detection 
techniques employed in the field, discuss issues concern-
ing breath sampling and biochemistry, and highlight the 
potential of breath analysis for disease diagnosis [22]. The 
status of optical spectroscopy based on mid-IR quantum 
and interband cascade lasers for detection of different bio-
markers in breath is reviewed by Risby and Tittel [23]. 
The emphasis in the review by Stacewicz et al. [24] lies 
on detection of biomarkers using three different absorption 
spectroscopy techniques. Detailed technical descriptions 
of the experimental setups, which were developed by the 
authors, are provide in [26]. Wang and Sahay [25] explain 
the basic working principles of different laser spectro-
scopic techniques, and present promising biomarker mol-
ecules that can be targeted by laser spectroscopy, as well 
as their diagnostic significance. Next to the technologi-
cal developments, several other considerations need to be 
taken into account for clinical applications of breath analy-
sis: issues concerning sample collection and measurement, 
interferences, ambient air correction, etc. All these aspects 
have been discussed in details in the review articles [22, 
23, 27]; however, few considerations regarding these are 
discussed here as well.
This work presents an update of the current status of the 
optical methods for breath analysis over the last decade 
and reviews the clinical applications of promising laser 
spectroscopic methods: tunable diode laser absorption 
spectroscopy (TDLAS), cavity ring-down spectroscopy 
(CRDS), integrated cavity output spectroscopy (ICOS)/
cavity-enhanced absorption spectroscopy (CEAS), photoa-
coustic spectroscopy (PAS), quartz-enhanced photoacous-
tic spectroscopy (QEPAS), and optical frequency comb 
(OFC) spectroscopy. The selection of these techniques 
was based on their maturity and high potential for clini-
cal applications, as well as the frequency in which they 
have been applied in breath research. Some of the most 
recent applications (from the past 5 years) of these tech-
niques have been included to show the progress made from 
the laboratory demonstrator to commercial instruments 
used in clinical settings. Furthermore, the present review 
refers exclusively to the use of near and mid-IR sources in 
combination with the above techniques. A SWOT analy-
sis (strengths, weaknesses, opportunities, and threats) is 
provided for the laser-based methods within the clinical 
framework of breath research.
Our hope is that the laser-based spectroscopy community 
recognizes the potential of these methods in breath research. 
Although, no technique is perfect, optical spectroscopy has 
appealing features for clinical use that are presented in this 
article. By recognizing and utilizing its specific strengths, 
laser spectroscopy could provide a strong contribution to this 
rapidly evolving field.
2  Optical spectroscopy—basic principles 
and overview
The most common optical method used for exhaled breath 
analysis is ro-vibrational absorption spectroscopy, primar-
ily because it affords selective determination of absolute 
concentrations. Normally, the analysis is based on the 
measurement of either fundamental (mid-IR, 3–10 µm) 
or first overtone (near-IR, 1–2 µm) vibrational transi-
tions. In certain exceptional cases, electronic transitions 
in the visible or ultraviolet range can also be probed [25]. 
Emission transitions can also be exploited in some rare 
instances. A notable example is the very successful test 
for the diagnosis and monitoring of airway inflamma-
tion, based on detection of exhaled NO [28]. Measure-
ment based on chemiluminescence is the gold standard for 
the  FENO (fractional exhaled NO) analysis. The reaction 
of NO with  O3 produces an electronically excited state 
of nitrogen dioxide  (NO2) which decays via emission at 
wavelengths above 600 nm [29].
The detection limit that is achieved in breath analy-
sis by laser-based spectroscopy is determined by the 
sensitivity of the chosen technique. The sensitivity of an 
absorption measurement can be enhanced in two different 
ways: by either increasing the absorption path length or 
by increasing the signal-to-noise ratio. Only highly abun-
dant compounds in breath can be quantified by a standard 
single-pass absorption measurement. Such an example is 
the 13CO2/12CO2 isotope ratio analysis with non-disper-
sive infrared (NDIR) spectroscopy. This technology is 
clinically exploited with success in the urea breath test 
for H. pylori diagnosis [30] and evaluating the activity of 
drug metabolizing enzymes, using stable isotope-labeled 
substrates [31]. To detect molecules present in breath 
at concentrations less than one part-per-million (ppm) 
levels, the absorption path length can be increased, by 
either using a multipass cell (MPC) or employing a reso-
nant cavity-enhanced approach (e.g., CEAS, as defined 
above). In addition, the intensity of the optical beam can 
be modulated at a particular frequency to filter out instru-
mental noise with phase sensitive detection. Also, wave-
length (WMS) and frequency modulation spectroscopic 
(FMS) methods are used for increasing the signal-to-noise 
ratio. Alternatively, photoacoustic spectroscopy can be 
employed; other than measuring the decrease of laser 
intensity by absorption, photoacoustic measures the result 
of absorption via an increase in acoustic intensity. Com-
parable sensitivities to absorption spectroscopy with short 
optical path length (tens of centimeters) can be achieved.
The concentrations of analytes that can be detected, 
using a single setup, depend normally on the type of laser 
source that is used. Current standard implementations of 
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optical breath instrumentation use lasers with a limited 
tunability; this normally limits the number of analytes 
to a maximum of a few per instrument [32]. Wider tun-
able lasers can be used, such as optical frequency combs 
(OFCs). The spectral coverage will be increased signifi-
cantly, as well as the number of simultaneously accessible 
analytes.
3  Laser absorption spectroscopy
3.1  Tunable diode laser and multipass absorption 
spectroscopy
Tunable diode laser absorption spectroscopy (TDLAS) is 
an umbrella term for the absorption techniques employing 
a single-mode semiconductor laser in a single- or multipass 
configuration and/or use modulation techniques for noise 
reduction. Thus, TDLAS comprises direct (single-pass) 
absorption spectroscopy, WMS, FMS, as well as path-length 
enhancement by various MPCs, such as a Herriott cells, 
White cells, or ring cells.
Typical light sources include distributed feedback (DFB) 
diode lasers (0.7–3 µm) and vertical-cavity surface-emitting 
lasers (VCSELs) in the visible and near-infrared spectral 
range, as well as DFB interband cascade lasers (ICLs) 
(3–6 µm), quantum cascade lasers (QCLs) (4–14 µm), and 
liquid nitrogen cooled lead salt tunable diode lasers in the 
mid-infrared [33]. These lasers allow mode-hop free wave-
length tuning in a narrow wavelength range (1–5 cm−1) by 
varying the injection current or temperature, and usually 
enable simultaneous targeted detection of 1–3 species with 
low molecular weight. For extended multispecies detec-
tion, two (or several) narrowband lasers can be combined 
[34, 35]. Another approach is to use external-cavity diode 
lasers (ECDLs) and external-cavity quantum cascade lasers 
(EC-QCLs), where the laser is mounted in an optical cavity 
comprising a wavelength selective device, which provides 
a narrow linewidth and broadband wavelength tuning range 
(up to 100 cm−1) [36].
Setups based on direct absorption spectroscopy, which 
can only be used to detect the highly abundant species in 
breath carbon dioxide  (CO2) and water vapor  (H2O) [35–37], 
usually achieve a Noise Equivalent Absorption Sensitivity 
(NEAS) of  10−3–10−5 cm−1Hz−1/2. The online, real-time 
measurement and analysis of  CO2 exhalation profiles (cap-
nography) with NDIR spectroscopy is by far the most widely 
used application of breath analysis in clinical practice. Using 
modulation techniques and/or MPCs, the sensitivity can be 
increased by orders of magnitude. For example, sensitive 
detection of exhaled carbon monoxide (CO) was achieved 
with single-pass WMS [38]. The most sensitive and most 
frequently used TDLAS approach in breath gas analysis, 
however, is to combine WMS with multipass enhance-
ment. With a typical NEAS of  10−8 cm−1Hz−1/2 and mak-
ing use of the strong fundamental molecular transitions in 
the mid-infrared, detection limits in the low ppb range can 
be achieved for numerous important breath biomarkers (see 
Table 3). A typical experimental MPC/WMS setup is shown 
in Fig. 1a.
Real-time breath analysis is sometimes incompatible with 
the need for high sensitivities, which is usually achieved 
using long signal integration times (tens of seconds). In 
addition, the time resolution is also restricted by the large 
sample volume (around 0.5 L) of typical multipass cells, 
which limits the gas exchange time. Real-time breath gas 
analysis with sub-second acquisition times [34, 35, 38–40] 
is achieved for more abundant species, such as CO, e.g., 
Fig. 1  a Schematic drawing of a typical mid-infrared TDLAS setup 
employing an ICL, a circular, low-volume MPC, and WMS (with per-
mission from [39]). LDC: laser diode controller, LiA: lock-in ampli-
fier, FGen: function generator, PT: pressure transducer, PD: photode-
tector. b Real-time, exhalation profiles (breath cycles) of CO and  CO2 
measured with an EC-QCL, and a  CO2 profile recorded with NDIR 
spectroscopy (capnography) (with permission from [36]). The three 
exhalation phases (dead space/airways, transition region, and alveolar 
region) are indicated
Laser spectroscopy for breath analysis: towards clinical implementation 
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using low-volume circular MPCs cells [36, 39]. An example 
of real-time detection of CO and  CO2 exhalation profiles is 
shown in Fig. 1b.
Carbon monoxide, recently identified as a cellular signal 
molecule, is one of the biomarkers currently investigated 
[34, 36, 38, 39] with WMS and/or MPC enhanced TDLAS. 
Since the main endogenous CO sources are systemic and the 
metabolism of heme, this molecule is a potential biomarker 
for oxidative stress and respiratory diseases. As exposure to 
exogenous CO (smoking, air pollution) can obscure systemic 
contributions; the clinical significance of CO is currently 
under investigation. Compared to traditional electrochemical 
CO sensors (used to assess smoking status), TDLAS-based 
CO detection offers much better sensitivity, precision and 
time resolution, and thus is better suited to the study of CO 
physiology.
To summarize, TDLAS and multipass absorption spec-
troscopy offer good sensitivity and selectivity at high spec-
tral and temporal resolution with potentially compact and 
affordable setups. Most of the implementations do not 
require calibration (using standard instrumentation with 
higher accuracy) to obtain quantitative results with high 
accuracy and precision. The method is suitable for the selec-
tive detection of exhaled breath biomarkers with end-tidal 
concentrations down to the low ppb range and rather strongly 
absorbing molecular transitions. For the main breath species 
and biomarkers with end-tidal levels around 1 ppm (CO, 
 CH4,  NH3, and  N2O), real-time detection and compact setups 
are within reach. Thus, in practice TDLAS is well-suited for 
targeted detection of one or a few such biomarkers, which so 
far has been one of the most successful application of breath 
tests in clinical applications.
3.2  Absorption spectroscopy with external optical 
resonators
Many breath biomarkers are present at low ppb level or 
below and have weakly absorbing molecular transitions. 
Thus, to attain the necessary sensitivity and selectivity, 
ultra-sensitive cavity-enhanced absorption spectroscopy 
methods must be employed.
Compared to multipass cells, the absorption path length 
can be further increased by exploiting the principle of cav-
ity-enhanced absorption (CEA). In CEA experiments, the 
breath sample is enclosed in a high-finesse optical cavity. In 
such systems, an optical cavity the absorption path length is 
dependent on the reflectivity of the cavity mirrors and can 
reach tens of kilometers in path length (with compact set-
ups of ≈ 1 m long cavity), especially in wavelength regions 
where the mirror coating technology is advanced (i.e., the 
Telecom wavelength range). In the mid-infrared wavelength 
region, the mirror reflectivity is normally less impressive. 
However, this is compensated by the stronger absorption 
line strengths of the molecular transitions. In principle, 
all laser types used for TDLAS can also be used for CEA 
instruments.
CEA experiments can be found in many different set-
tings. One of the most common approaches is to record the 
time evolution of the laser intensity inside the optical cav-
ity and extract the time constant of decay. This approach 
is cavity ring-down spectroscopy (CRDS) and has been 
employed in a number of breath investigations [26]. Alter-
natively, the total amount of laser intensity that leaks out of 
the cavity can be recorded. Depending on the experimental 
details, the method is called either integrated cavity output 
spectroscopy (ICOS) or simply cavity-enhanced absorp-
tion spectroscopy (CEAS), depending on the author. The 
excitation of the optical cavity can be performed in various 
configurations and this leads to adapted acronyms: off-axis 
cavity-enhanced absorption spectroscopy (OA-CEAS) and 
optical feedback cavity-enhanced absorption spectroscopy 
(OF-CEAS). Typical sensitivities that can be achieved are 
in the  10−10–10−11 cm−1Hz−1/2 range.
3.2.1  Cavity‑enhanced absorption spectroscopy
In many breath studies, “static” samples of breath are probed 
using instrumental averaging times ranging from several 
seconds to minutes. However, real-time laser spectroscopic 
measurements can yield important physiological and medi-
cal information of the main respiratory gases within a breath 
cycle.
A significant example is the recent work by Ciaffoni 
and co-workers [35] who have developed a sensor for the 
determination of oxygen consumption  (VO2) on a breath-by-
breath basis at the mouth of an intubated patient undergo-
ing anesthesia and/or mechanical ventilation. The analyzer, 
termed a molecular flux sensor (MFS), uses diode laser 
absorption within an optical cavity [41] in combination with 
a state-of-the-art flow meter. The latter is instantly adaptable 
(10 ms resolution) to changing gas compositions. Here, a 
novel advance has been observed whereby the sensitivity of 
the CEAS measurement is improved by the application of 
broadband radiofrequency noise to the laser [42]. The MFS 
device has reduced the bias in flow sensing between inspi-
ration and expiration from ~ 5% to < 0.2% and allows the 
quantification of clear and evident physiological responses 
to standard practice. This device allows the clinical stud-
ies necessary to understand the effects of a range of com-
mon interventions on  VO2 in patients in various degrees of 
shock; these interventions include the use of fluids, blood 
transfusions, elevated oxygen, and vasoactive drugs. Such 
studies are a pre-requisite for the design of a goal-directed 
algorithm for an interventional clinical study using  VO2 to 
titrate therapy.
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Most recently, the same group has recognized that the 
highly precise and time-resolved MFS data afford the 
opportunity to extract information pertaining to inho-
mogeneity in the lung from a period of steady breathing 
followed by a  N2 multi-breath washout (MBW) phase 
(Fig. 2). The shape of the  N2 MBW phase encodes a meas-
ure of the width of the alveolar ventilation to volume dis-
tribution, while the profiles, by which  CO2 and  O2 emerge 
during expiration, encode a measure of anatomic dead 
space and its distribution in the lung. Asymmetry between 
the  CO2 and  O2 “expirograms” reflects the distribution of 
ventilation to perfusion ratio in the lung, a consequence of 
differences in blood gas chemistry between the two [43].
Mountain et al. [44] have developed a model for lung 
inhomogeneity. The model has a parameter set that can 
be identified from measurements of respiratory gas flow, 
using the in-airway MFS. Key parameters that can be 
recovered are the standard deviations (σ) for the distribu-
tions: (1) in dead space (the volume of air which is inhaled 
that does not take part in the gas exchange, either because 
it remains in the conducting airways, or reaches alveoli 
that are not perfused or poorly perfused); (2) in fractional 
lung compliance (a measure of the lung’s ability to stretch 
and expand); and (3) in fractional vascular conductance (a 
measure of blood flow through the lung).
Notably, the MFS has been used to obtain pilot data from 
lung washouts, studying six healthy young participants 
(20–30 years), six healthy older participants (70–80 years), 
and six patients with chronic obstructive pulmonary disor-
der (COPD), repeating the protocol on each participant six 
times. The model fitted the data well and parameter values 
were highly repeatable from test-to-test. Analysis of variance 
revealed highly significant differences between individuals 
within groups, and between groups for all three parame-
ters—the individual values for σ for all COPD patients were 
always higher than those for any of the control participants. 
As an example, Fig. 3 shows the distributions for standard-
ized compliance, CL*, and conductance, Cd*, for each par-
ticipant group, and there is a clear increase in the width 
of the distributions for the COPD group. Furthermore, the 
distribution of dead space was found to be markedly larger 
for COPD patients. These initial results indicate that such 
measurements are capable of stratifying lung disease [44].
3.2.2  Optical feedback cavity‑enhanced absorption 
spectroscopy
Optical feedback cavity-enhanced absorption spectroscopy 
(OF-CEAS) solves one of the most pertinent problems of 
CEAS implementations, the difficulty of injecting a suffi-
cient amount of laser light into a very high-finesse optical 
Fig. 2  a Schematic of the multichannel absorption spectrometer 
and pneumotachograph within the MFS measurement head. The bi-
directional gas path (blue) is shown along with the two mesh screens 
(gray), across which pressure drop is measured. Radiation used for 
probing  O2 is injected into an optical cavity constructed from a pair 
of highly reflective mirrors (red) and collected by a photodiode (PD 
1) positioned along the optical axis (green). Radiation probing  CO2 
and  H2O vapor is launched into the v-path (yellow), reflected by a 
concave mirror, and collected by the photodiode (PD 2). The physical 
length of the optical cavity is commensurate with the diameter of a 
standard medical ventilation tube. b, c Dry gas fractions of  N2 (pur-
ple),  O2 (green), and  CO2 (red) measured in real time (every 10 ms) 
as a participant breathes through the measurement head. The dry 
fraction of  N2 is determined by the subtracting the dry fractions of  O2 
and  CO2 from unity. b Data from an air breathing phase. c Data from 
the early stage of a nitrogen washout procedure
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cavity, while providing a good spectral resolution and high 
signal-to-noise ratio. This spectroscopic method has been 
described in detail in several publications [45–47]. Here, 
we just present its basic principles. Like the other CEAS 
methods, OF-CEAS achieves a high sensitivity by the use 
of a resonant optical cavity as the sample cell. The effective 
absorption path length can then easily reach tens of kilome-
ters, with a very compact setup. The originality of OF-CEAS 
is that the optical cavity is made of three mirrors placed in a 
“V-shaped” configuration (Fig. 1 in [45]). In this way, a frac-
tion of the light trapped inside the optical cavity, and there-
fore frequency-selected by the cavity, can be returned to the 
laser. The nonlinear response of the laser is then exploited 
to force lasing on the exact frequency of the excited cavity 
“mode”. This “optical feedback” (OF) effect is also respon-
sible for a narrowing of the laser emission line width with a 
consequent increase of the cavity transmission together with 
a reduction of the noise (which normally results from the 
coupling of narrow cavity modes with a relatively broader 
laser line). The resulting signal-to-noise ratio is orders of 
magnitude larger than in other spectroscopic methods [47]. 
The cavity length is typically 1 m (folded to an external base 
length of just 50 cm), while the effective absorption path 
length easily reaches tens of kilometers.
Using DFB diode lasers or ICLs/QCLs, OF-CEAS 
absorption spectra are acquired in a small spectral region 
(~ 1.5 GHz), by scanning the laser frequency at a relatively 
fast rate (~ 10 Hz). However, the response time is not lim-
ited by this rate but rather by the gas exchange inside the 
measurement volume. Therefore, the cell is designed with 
minimal dead space and a small sample volume of less than 
20 cm3. The gas sample can be injected in a continuous 
flow with a stabilized, relatively low cell pressure, and its 
exchange time depends on the flow and pressure. It can be 
made below 1 s, for example, by setting a flow of 8 mL/s 
with a cavity pressure of 140 mbar [46]. If required, it can 
be further improved using a lower pressure and/or a higher 
pumping rate. Finally, the design of the spectrometer is 
robust and compact: the optical assembly and all the elec-
tronics for real-time control and data acquisition fit inside 
a 19″ chassis.
Successful inter-comparison of OF-CEAS analyzers and 
mass spectrometer [48] as well as gas chromatograph have 
been reported [49]. A real-time numerical fit of the meas-
ured absorption spectra enables the selective determination 
of the concentrations of all compounds that possess absorp-
tion lines in the selected spectral window. This is a key point 
in breath analysis, as expired air has a highly complex gas 
mixture.
OF-CEAS analyzers have been developed in the NIR 
since 2005 with DFB diode lasers. The smallest detect-
able absorption coefficient is typically on the order of 
5 × 10−10 cm−1Hz−1/2 in this spectral region [47]. As an 
example, an OF-CEAS instrument optimized for monitor-
ing exhaled CO at 2.33 µm (4297.7 cm−1) offers a 0.2 ppb 
detection limit for CO over an acquisition time of 20 s [50]. 
More recently, a few OF-CEAS prototype setups in the MIR 
were reported based on QCL [51, 52] and lately, based on 
ICLs [53–55], presenting an absorption detection limit in 
the range of  10− 9 cm−1Hz−1/2. This level of sensitivity of 
OF-CEAS analyzers in the mid-IR results directly from its 
high signal-to-noise ratio compensating for the lower detec-
tivity of optical detectors at longer wavelengths. Reaching 
this spectral region is of special interest for clinical applica-
tions, since it allows trace detection of NO, a well-studied 
molecule by clinicians. In particular, an OF-CEAS analyzer 
developed with a QCL at 5.26 µm (1900.5 cm−1) achieves 
a sensitivity of 80 ppt of NO for a single measurement per-
formed in 140 ms. The stability of the instrument allows 
averaging for 10 s to reach ~ 10 ppt [56].
Fig. 3  Contour plots for the bivariate log normal distributions for 
(standardized) compliance and conductance for three participant 
groups: young, old, and COPD. Contour intervals are values for the 
probability density function. The increased lung inhomogeneity for 
COPD cohort is readily apparent from the widths of the distribution. 
Further details can be found in Mountain et al. [44]
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OF-CEAS analyzers in the NIR have been successfully 
used in two independent medical settings. First, the tech-
nique was validated at the Bichat Hospital (Paris, France), 
monitoring patients’ exhaled CO and methane  (CH4) in the 
framework of bronchial inflammation diagnostics. Similar 
to results presented above in 2.3.1, OF-CEAS measurements 
were performed simultaneously to spirometer records to 
trace out levels of CO and  CH4 during different ventilatory 
phases [46]. More recently, in collaboration with Grenoble 
University Hospital, the role of the exhaled CO and NO as 
biomarkers for the selection of lung grafts for transplantation 
is being investigated. This study, in the tightly controlled 
clinical setting of organ transplantation, is driven by the 
need of new markers for the re-habilitation of pulmonary 
grafts initially rejected for transplant. Evaluation of isolated 
lungs occurs in an ex vivo lung perfusion (EVLP) device: 
lungs are perfused and ventilated in a closed container [57]. 
As a first demonstration, by analyzing the gas in the ventila-
tor line, the endogenous CO produced by isolated pig lungs 
was measured by OF-CEAS during the progressive rewarm-
ing of the lung after cold ischemia (Fig. 4). These meas-
urements on the isolated organ deliver CO concentrations 
that are one order of magnitude smaller than measurements 
performed on the entire living body [58]. In that study, the 
level of CO production could be correlated to the severity 
of ischemia–reperfusion injury in EVLP [59], opening the 
path towards the definition of threshold values of exhaled 
CO, clinically relevant for EVLP procedures. The monitor-
ing of endogenous gas production for lung graft evaluation 
is currently on going. First, still on the animal model, NO 
measurements will be performed. Indeed, NO is a major 
signaling gas transmitter involved in pulmonary inflamma-
tion. It is then very attractive to exploit recent developments 
of OF-CEAS analyzer in the mid-IR that allow the required 
sub-ppb sensitivity for NO measurements in isolated lungs 
[60]. Second, measurements are planned during human lung 
transplantations.
4  Laser photoacoustic spectroscopy
4.1  Principles and overview of photoacoustic 
spectroscopy
Like other laser spectroscopic methods, laser photoacous-
tic spectroscopy (LPAS) is able to monitor gas absorptions 
in a fast and sensitive way. Cavity-enhanced spectroscopic 
methods derive their high sensitivity from long absorption 
path lengths (km). Laser photoacoustics has the advantage 
that the absorption path length is kept very short (mm to 
cm) and that the signal is background free (i.e., no signal is 
detected in the absence of absorbers). The method does not 
rely on a decrease of the transmitted light intensity, but on an 
increase from a zero baseline, i.e., on release of energy via 
collisions after absorption. Depopulation of excited energy 
levels occurs either via fluorescence or collisions. Colli-
sional de-excitation is favorable in the infrared wavelength, 
due to long fluorescence lifetime in the IR, especially at 
atmospheric pressures [61]. Due to the transfer of vibrational 
to translational energy, the temperature of the gas increases. 
By modulating the radiation source, the temperature will 
change periodically, giving rise to a periodical pressure 
change, resulting in an acoustic wave that can be detected 
by a microphone.
Photoacoustic spectroscopy serves as a very sensitive, 
efficient, easy, and robust analytical method. In addition, 
LPAS is relatively cheap and can be used in a very wide 
wavelength range limited only by the infrared transmit-
tance of the window materials. This is in contrast to CEA, 
in which the wavelength dependence of the highly reflective 
mirror coatings limits the spectral coverage of the system. In 
comparison to direct absorption methods, the photoacoustic 
signal is proportional to the optical power. From the Lam-
bert–Beer law one finds for small absorptions:
in which S is the photoacoustic signal detected by the micro-
phone (in V), P is the laser power (in W), A is the conver-
sion efficiency, 휎(휐) is the absorption cross section of the 
molecule (in  cm2) at frequency 휐 , n is the number of mol-
ecules per  cm3, and l is the absorption path length (in cm). 
The constant A quantifies the conversion efficiency, which 
(1)S = A ⋅ P ⋅ 휎(휐) ⋅ n ⋅ l
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Fig. 4  a CO measurements performed by OF-CEAS on an ex  vivo 
pig lung during slow warming after cold ischemia. The response time 
allows to monitor both inspiration and expiration phases imposed by 
the ventilator (respiratory rate is 12 per min). The baseline corre-
sponds to CO concentration in the medical gas supply. b Lungs were 
progressively ventilated and rewarmed by a perfusion solution
Laser spectroscopy for breath analysis: towards clinical implementation 
1 3
Page 9 of 21 161
depends on the acoustic geometry of the cell, sensitivity of 
the microphone, signal amplification, etc.
Due to its high sensitivity, LPAS allows single breath 
collection from a small sampling volume (few 100 ml) with 
no pre-concentration steps needed. Within LPAS a high sen-
sitivity can be achieved with high-power infrared lasers. In 
addition, a wide-tunability is required to selectively detect 
gases in complex gas mixtures and to operate at the optimal 
wavelength region to minimize spectroscopic interference 
from other gases such as water. Such widely tunable high-
power lasers are available, for example  CO2 lasers, optical 
parametric oscillators (OPOs) [32], or EC-QCLs, the latter 
being used to determine glucose concentration in human 
skin [62] and NO detection [63].
An early example illustrating the possibility of LPAS 
trace gas detection for breath analysis is the investigation of 
the effect of UV-radiation on the human skin. Under stress 
conditions (e.g., ionizing radiation, toxic chemical sub-
stances, and diseases), the production of free radicals in the 
body is significantly increased. Subsequently, the capacity 
of the free radical scavengers in the body is overloaded and 
a chain of chemical reactions is activated [64]. This leads 
ultimately to cell membrane damage (i.e., lipid peroxida-
tion, oxidation of fatty acids in cell membrane) that plays 
an important role in the aging processes and pathogenesis 
of some diseases. The cell damage is accompanied by the 
production of light hydrocarbons such as ethane, pentane, 
and ethylene that can be easily measured with an intracavity 
 CO2 laser using photoacoustic lab setup [65, 66].
This investigation is recently extended to a clinical set-
ting, with the assessment of lipid peroxidation by expired 
ethylene during cardiac surgery (Fig. 5) using a commer-
cial  CO2 laser-based photoacoustic detector with a detection 
limit of 300 ppt in 5 s (Sensor Sense, The Netherlands). Dur-
ing this surgery, patients were undergoing aortic or mitral 
valve surgery-requiring cardiopulmonary bypass and off-
pump coronary artery bypass surgery. The study revealed, 
for the first time, the real-time signatures of the surgical 
response triggered by oxidative stress including lipid per-
oxidation (Fig. 6) [67]. This innovative approach has irrefu-
tably demonstrated the significant contribution of diathermy 
to overall oxidative stress and identified increased ethylene 
associated with regional myocardial ischemia on an indi-
vidual basis. It can be concluded that sensitive, totally non-
invasive, and real-time analysis of lipid peroxidation using 
breath ethylene is feasible in the clinical and perioperative 
setting [68].
Fig. 5  Laser-based photoacoustic detector (ETD-300, Sensor Sense) 
in the cardiothoracic surgery department at Harefield hospital, UK 
(photo by S. Cristescu)
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Fig. 6  Intraoperative real-time monitoring of ethylene measured 
by LPAS in patients undergoing off-pump coronary artery bypass 
surgery. a Example of continuous monitoring during of the entire 
operation. At t = 0 h the patient was connected to the sampling line; 
DT = diathermy electrocautery with high-frequency electric currents 
(adapted from [67]). b An example of a grafting procedure. The high-
resolution peaks are associated with ethylene induced by lipid peroxi-
dation during the reperfusion events
 B. Henderson et al.
1 3
161 Page 10 of 21
Mid-infrared OPOs are considered amongst the most use-
ful tools for sensitive LPAS gas sensing, due to their high 
power (Watt level), wide tuning range, and ease of tunability. 
Such a light source was successfully applied for the detec-
tion of hydrogen cyanide (HCN) in exhaled breath of cystic 
fibrosis (CF) patients being infected with various bacteria, 
namely Pseudomonas aeruginosa, Staphylococcus aureus, 
etc. [69, 70]. In high concentrations HCN is toxic, but it may 
also originate endogenously (in small amounts), from patho-
gens [69–71] or ingestion of food [32]. Infections with these 
bacteria are of particular significance to CF patients, due to 
their association with an increased morbidity and mortality. 
Therefore, it is important to be able to detect these bacterial 
infections as early as possible. Current diagnostic techniques 
lack sensitivity (cough swab), are very invasive, and com-
monly miss early infections, especially in young children.
4.2  Quartz‑enhanced photoacoustic spectroscopy
The current field of medical applications demands not only 
better quantification of exhaled gases with high sensitivity 
and fast time-response, but also portable devices with low 
power consumption. Quartz-enhanced photoacoustic spec-
troscopy (QEPAS) can meet these demands to a large extent. 
The common approach in gas phase LPAS spectroscopy is 
to use a resonant photoacoustic cell, but this can be replaced 
by a tuning fork therefore decreasing the sampling volume. 
Tuning forks are mass produced and inexpensive; every elec-
tronic watch or clock is built around a high-Q quartz crystal 
frequency standard. The resonance frequency (32 kHz) of 
the fork corresponds to a symmetric vibration (the prongs 
move in opposite directions). The antisymmetric vibration is 
piezoelectrically inactive. A typical tuning fork has at nor-
mal atmospheric pressure a Q-value of 8000. Special fea-
tures are: (a) ambient acoustic noise is low at those frequen-
cies; (b) external sound will not excite the piezoelectrically 
active mode of the prongs; (c) the width of resonance is 4 Hz 
(at atmospheric pressure) and only frequency components 
in this narrow spectral band can produce efficient excita-
tion of the TF vibration; and (d) the gas sampling volume is 
extremely small (0.15 mm3) [72].
There are a number of examples of breath studies using 
QEPAS, such as: (i) determining the 13CO2/CO2 ratio from 
human breath for identification of Helicobacter pylori infec-
tion, liver malfunction, and excessive growth of bacteria in 
the body [73]; (ii) the detection of carbon disulfide  (CS2) 
to indicate cirrhosis and a potential non-invasive marker of 
respiratory bacterial colonization in cystic fibrosis [74]; and 
(iii)  NH3 detection as product of protein metabolism relevant 
for a number of disease states and human physiology [75].
To develop a QEPAS system portable, dedicated mid-
infrared Interband Cascade Lasers (ICL) or Quantum 
Cascade Lasers (QCL) can be used. A typical scheme of 
a fiber-coupled portable QEPAS setup is shown in Fig. 7 
[73]. In this setup, light emitted from the ICL is coupled into 
a solid-core  InF3 fiber. The fiber output is directed through a 
stainless-steel micro-resonator tube (a small acoustic reso-
nance cell). A small slit in the middle of the resonator tube 
couples the resonant acoustic energy into the quartz tuning 
fork placed next to the resonator tube. All the QEPAS sens-
ing elements were enclosed in a compact gas sensor with a 
size of 6 × 5 × 6 cm, with miniaturized drivers, amplifiers 
and software-based signal processing methods. This system 
was used to determine  CO2 isotopic ratios with a precision 
of < 1%.
5  Optical frequency comb spectroscopy
An Optical frequency comb (OFC) combines the advan-
tages of narrow linewidth cw lasers with those of broad-
band supercontinuum light sources. The spectrum of an OFC 
consists of hundreds of thousands of synchronized coherent 
modes, spanning a broad wavelength range. This feature 
makes OFC an ideal source for sensitive, broadband and 
high-resolution spectroscopy. Their potential in simultane-
ous detection of different biomarkers in human breath has 
been already demonstrated in the near-IR wavelength range 
using cavity-enhanced optical frequency comb spectroscopy 
(CE-OFCS) [76], where trace concentrations of CO,  NH3, 
and methane  (CH4) in exhaled breath were detected in the 
presence of high concentrations of water vapor  (H2O) and 
carbon dioxide  (CO2). The distinct combination of broad 
Fig. 7  A scheme of the fiber-coupled off-beam QEPAS sensor for 
 CO2 isotopic ratio determination [73]. L1, AR-coated aspheric lens; 
L2, optical focuser; QTF, quartz tuning fork; mR, micro-resonator; 
DAQ, data acquisition system
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spectral bandwidth and high spectral resolution of the fre-
quency combs makes it possible to detect molecules with 
broad absorption features and at the same time discriminate 
and characterize the interfering species, yielding a selective 
multispecies detection advantage.
Although most of the important species for biomedical 
applications have their strongest ro-vibrational transitions in 
the mid-IR, the OFCs are traditionally generated from the 
mode-locked lasers whose spectrum usually covers the visi-
ble and near-IR wavelength ranges, while reliable mode-lock 
laser emitting in mid-IR are still under development [77]. 
To reach the mid-IR wavelength range two main different 
approaches are most often used [78]: nonlinear frequency 
conversion such as optical parametric oscillation (OPO) 
or difference frequency generation (DFG) in combination 
with near-IR mode-locked lasers, or alternatively generat-
ing mid-IR comb directly from semiconductor lasers. Other 
approaches such as using microresonators to generate mid-
IR combs are under development [79].
OFCs based on nonlinear conversion have been used to 
detect different volatile compounds connected with potential 
breath analysis applications, such as methane and nitrous 
oxide  (N2O) using OPOs with a cavity-enhanced absorp-
tion and Fourier Transform Spectrometry (FTS) [80];  CH4, 
formaldehyde  (CH2O),  C2H4 and CO using intracavity detec-
tion with an OPO and FTS [81];  CH4 using DFG and an 
Optical spectrum analyzer (OSA) [82]; and  CH4, CO and 
NO using an OPO with a multipass cell and FTS [83]. Dif-
ferent broadband spectroscopic methods such as Virtually 
Imaged Phase Array (VIPA) spectroscopy [84], Vernier 
spectroscopy [85], and dual-comb spectroscopy [86, 87] are 
also utilized in the MIR range yielding faster measurement 
times and/or higher detection sensitivity paving the way 
towards achieving the specifications needed for biomedical 
applications. In addition, the recent dual-comb spectroscopic 
results using a DFG [88] or an OPO [89] based on an Ori-
entation Patterned Gallium Phosphide (OPGaP) crystal—a 
newly developed nonlinear material—extend the available 
detection wavelength range to 12 µm. Despite all of the 
advantages and recent advances of the mid-IR spectroscopy 
systems based on nonlinear conversion, they are still com-
plicated, bulky, and expensive; which seems to be the main 
drawback of utilizing these systems in actual biomedical 
applications until now.
The second main approach is to use semiconductor mode-
locked lasers, specifically QCLs, for generating mid-IR 
combs [90] and implement a compact dual-comb spectros-
copy system [91, 92]. The potential of these spectroscopy 
systems in detection of different biomarkers such as  NH3 
and  N2O [91, 93] has been shown; however, their sensitiv-
ity needs to be significantly improved, e.g., using enhance-
ment cavities, to make them appropriate for biomedical 
applications. These systems are commercially available, 
quite compact, robust and rather inexpensive. However, 
compared to the mid-IR combs based on nonlinear conver-
sion and mode-locked lasers, the QCL-based combs have 
typically one to two orders of magnitude narrower spectral 
bandwidths and higher repetition rates. Narrower spectral 
bandwidths potentially restrain the multispecies detection 
capability, and higher repetition rates—assuming no spec-
tral interleaving [94]—limit the spectral resolution of the 
spectrometers based on these sources making them more 
appropriate for spectroscopy of liquid and solid samples. A 
brief comparison between the key features of the available 
mid-IR spectrometers based on OPO/DFG generated combs 
and QCL generated combs is presented in Table 1.
6  Performance comparison and SWOT 
analysis
Here, we present a performance comparison of the presented 
laser-based techniques with typical mass spectrometers 
and sensor arrays (Table 2), as well as a SWOT analysis 
(strengths, weaknesses, opportunities, and threats) for the 
laser-based techniques in the following subsections. The 
Table 1  Comparison between 
the key features of typical 
mid-IR spectrometers based on 
OPO/DFG generated combs and 
QCL generated combs
Specification mid-IR spectrometers based on OPO/
DFG combs
mid-IR spectrometers based on 
QCL combs
Possible spectral coverage 2.5–12 µm 5–12 µm
Spectral bandwidth Up to ~ 1500 cm−1 Up to ~ 150 cm−1
Spectral tunability Yes No
Typical repetition rate (spectral 
sampling)
~ 100 MHz ~ 10 GHz
Average output power Up to ~ 250 mW Up to ~ 1 W
Detection sensitivity High (w/cavity enhancement) Low (w/o cavity enhancement)
Complexity High Low
Size Bulky Compact
Cost Expensive Inexpensive
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aim is to position the laser spectroscopy within the breath 
research field, and to give examples of the latest technologi-
cal advances and applications in clinical environments.
6.1  Strengths
Although the literature on breath analysis seems dominated 
by mass spectrometry and other non-optical sensors, the 
breath tests approved by the US Food and Drug Admin-
istration [95] include numerous optical-based measure-
ments, such as urea breath test, capnography and  FENO 
(chemiluminescence—“semi-optical”). Interestingly, with 
one exception, namely the test for heart transplant rejec-
tion  (C4-C20 alkanes and branched chain alkanes) [96], most 
of the FDA approved tests are single-species tests. This is 
where the strength of optical methods lies in: specific, reli-
able, and quantitative, real-time analysis of single analytes, 
and often without the need for (frequent) calibration. In 
Table 3, representative molecules of medical interest that 
have been detected in (mostly) breath samples with near- and 
mid-infrared laser-based spectroscopic methods are listed. 
Depending on the specific experimental setup, measure-
ments have been performed in real-time (sub-second time 
resolution, resolving individual breath cycles) or near-real-
time (not resolving breath cycles, but analysis complete in 
time scale of minutes).
Recent advances in nanotechnologies, optoelectronics, 
and photonics integration reinforce the demand for com-
pactness and miniaturization of the devices. Non-specific 
sensors assembled into arrays that respond to different odors 
by generating a complex signal, e.g., the electronic nose or 
semiconductor-based sensor array, have become popular and 
have been used in clinical applications [144–146]. They are 
relatively inexpensive, small, easy-to-use, but lack both sen-
sitivity and selectivity, require frequent calibrations, drift 
over time, have memory effects, are sensitive to changes 
in humidity and temperature and cannot identify individual 
compounds [25, 147]. Moreover, since a limited number of 
specific sensorial elements are used, it is mandatory to know 
which compounds will be targeted and/or the composition 
matrix of the background [144–146]. Optical techniques are 
by far more sensitive and selective, are virtually maintenance 
free and can operate continuously for long periods of time. 
For example, in comparison with a traditional electrochemi-
cal CO sensor (used to access smoking status), TDLAS-
based CO detection (see Sect. 3.1) offers much better sensi-
tivity, precision and time resolution, and thus is better suited 
to study the CO physiology.
Importantly, OF-CEAS provides quantitative absorption 
measurements in real time without the need for periodic 
calibration (using certified gas mixtures). A normalization 
procedure of the absorbance scale is realized by performing 
a single CRDS measurement at the end of each OF-CEAS 
spectral scan [148]. In addition, OF-CEAS is an ultra-sen-
sitive technique allowing selective real-time measurements 
using a small sampling volume with the response time faster 
than a single respiratory cycle. Since it enables the devel-
opment of compact instruments to be operated by non-spe-
cialists in a medical environment it also offer commercially 
attractive commercial perspective (e.g., OF-CEAS analyzers 
are currently commercialized by AP2E, France).
6.2  Weaknesses
In contrast to standard analytical techniques (e.g., GC-MS), 
laser-based spectroscopy is mainly used in research focused 
on a single identifiable molecule or a small combination of 
molecules whose biochemistries are known. Simultaneous 
multispecies detection in breath with optical methods has 
only been demonstrated for few species at a time, at trace 
levels (ppb and below).
Indeed, in the exploratory/discovery phase of breath 
research, instrumentation that can probe only single ana-
lyte is not (necessarily) sufficient. In many cases it would 
Table 2  Performance of LAS techniques as compared to other analytical methods in the field of breath gas analysis, based on included refer-
ences. Real-time—online sampling and breath-cycle resolved detection, VOCs—volatile organic compounds
Technique Sensitivity Selectivity/precision Real time Multispecies Complexity/size/cost Comments
Laser based
TDLAS and MPC Intermediate High Yes 1–3 Low to intermediate Light molecules
CEAS High Yes 1–3 Intermediate
PAS High No 1–3 Intermediate
OFCS Intermediate Not yet Yes High Light mol. and VOCs
MS
GC-MS High Intermediate No Yes High VOCs, calibration
PTR-MS
SIFT-MS
High Intermediate Yes Yes High VOCs, calibration
Sensor arrays Intermediate Poor No – Low Calibration
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Table 3  Representative molecules of medical interest determined with laser-based spectroscopic methods in near- and mid-infrared regions
Molecule λ (µm) Detection method Detection limit (measurement 
time)
Human tests/in vitro/application is 
breath, otherwise specified
Acetaldehyde 5.79 TDLAS/WMS 80 ppb (5 s) After alcoholic beverage [97]
Acetone ~ 8.2 ICOS 170 ppb (0.2 s) [98]
~ 3.3 ICOS 100 ppb (0.4 s) [99]
~ 3.3 TDLAS + multipass cell 14 ppb (15 min) Diabetes [100]
1.69 CEAS ~ 160 ppb [101, 102]
~ 8.2 TDLAS + multipass cell 150 ppb Diabetes [103]
~ 8.2 ICOS 30 ppb (30 s) [104]
Acetylene 1.52 CRDS 175 ppt (10 min) After smoking [105]
1.53 ICOS 1.5 ppb (128 s) After smoking [106]
Ammonia ~ 3 CRDS 0.3 ppb (30 s) Breath and skin [107, 108], during 
hemodialysis [109]
9.56 PAS 100 ppb (3 s) Hemodialysis [110]
9.56 QEPAS 10 ppb (1 s) [111], Exercise [112]
3.04 PAS 1 ppm (10 s) Bacteria [70]
10.3 CRDS 50 ppb (20 s) [113]
10.3 TDLAS + multipass cell 3 ppb (10 s) [114]
9.07 WMS + multipass cell 7 ppb (5 s) [115]
1.51 CE-OFCS 4 ppm (30 s) [76]
Carbon dioxide (isotopes) 1.60 CRDS 3 ppm (3 ms) [116]
1.60 CE-OFCS < 10 ppm (30 s) [76]
2.05 ICOS ± 0.15‰ precision for δ13DOB 13C‰
H. pylori infection [117, 118]
~ 2 ICAS ~ 100 ppb [119]
Carbon monoxide 4.57 TDLAS + multipass cell 0.8 ppb (1 s) Asthma, COPD [34]
4.59 TDLAS + multipass cell 14 ppb (60 s) [120]
4.72 WMS + multipass cell 0.6 ppb (15 s) Smoking [36]
4.61 ICOS/WMS 7 ppb (1 s) [38]
2.33 OF-CEAS 1 ppb (0.3 s) [46]
1.6 CE-OFCS 0.9 ppm (0.3 s) [76]
Carbon monoxide (isotopes) 4.69 WMS + multipass cell 0.6 ppb (10 s) [39]
Carbonyl sulfide 4.86 TDLAS + multipass cell 1.2 ppb (0.4 s) [121]
4.90 CRDS 7 ppt (1 s) [122]
Ethane 3.35 ICOS 0.48 ppb (1 s) [123]
3.34 ICOS 50 ppt (0.25 s) [99]
3.34 TDLAS/WMS + multipass cell 70 ppt (1 s) Dialysis [40, 124, 125]
~ 3.4 CRDS 0.5 ppb (0.8 s) [126]
~ 3.4 TDLAS + multipass cell 70 ppt (0.7 s) [127], Lung cancer [128]
3.34 CRDS 270 ppt (1 s) [129]
Ethylene 10.5 PAS 0.3 ppb (5 s) Cardiac surgery [67], Endotoxemia 
[130], skin [66]
10.5 PAS 100 ppb Renal failure [131]
Glucose ~ 9 PAS ~ 30 mg/dL (in blood) Skin [62]
Hydrogen cyanide 1.54 CRDS 0.3 ppb (2.5 min) Breath, skin [132], Oral fluid [133]
3.04 PAS 0.4 ppb (10 s) [69], in vitro [70]
Methane 1.65 PAS 0.3 ppm (12 s) [134]
2.33 OF-CEAS 25 ppb (0.3 s) [46]
~ 3.3 CRDS 1–10 ppb (120 s) [135]
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be useful to have an instrument that can analyze many 
volatile compounds. And this is where mass spectrometry 
still holds an advantage over optical methods. The gold 
standard in breath research is gas chromatography com-
bined with mass spectrometry (GC-MS) [149]. GC-MS 
allows the unambiguous identification of hundreds of 
volatile breath compounds and the method has been used 
extensively in exhaled breath studies. However, it is not 
suitable for online sampling and the analysis is not real 
time. Some form of pre-concentration (adsorbent traps, 
solid-phase micro-extraction) is required and standard 
analysis time is up to tens of minutes. These limita-
tions can be circumvented using soft chemical ionization 
instead of electron impact ionization. Instruments based 
on selected ion flow-tube mass spectrometry (SIFT-MS) 
and proton-transfer reaction mass spectrometry (PTR-MS) 
allow online sampling and real-time analysis while making 
it potentially possible to analyses dozens of VOCs simul-
taneously [150].
Few studies have carefully addressed the untargeted 
analysis of medium-to-high molecular weight species 
that absorb over a broad wavelength range [151]. As out-
lined in Sect. 5, demonstration experiments have been 
conducted using optical frequency combs, but practical 
routine implementations lie still in the future. However, 
once the technology matures, optical methods can start 
competing with real-time MS-based techniques such as 
PTR-MS, SIFT-MS, and SESI-MS, which are able to 
measure a broad range of VOCs. When broadband emis-
sion sources are used, such as EC-QCLs or OFCs, the 
main challenge is to develop robust algorithms that can 
discriminate between multiple absorbing molecules using 
their specific (narrowband or broadband) spectroscopic 
features. Even so, the existing possibility of scanning very 
fast over a broad spectral range to obtain a molecular fin-
gerprint of an unprecedented large number of gases with 
optical techniques is well worth exploring.
6.3  Opportunities
The technology of lasers has advanced considerably in the 
past few years and more wavelengths are available for gas 
sensing and applications outside the laboratory. Further-
more, new avenues have been opened for the design of com-
pact instruments. This has been demonstrated by examples 
presented in this article. The latest development of QEPAS 
(Sect. 4.2) allows the design of a gas sensor of less than 
220 cm3. The MFS approach described in Sect. 3.2.1 is prac-
tical in a clinical setting and has many attractive features in 
comparison to other methods for studying lung inhomogene-
ity: it is simple to undertake, it is non-invasive, it does not 
require ionizing radiation (unlike CT and PET), it does not 
require expensive scanners and reagents (unlike He and Xe-
MRI), and it is sufficiently simple to conduct that it could be 
undertaken in any standard lung-function testing laboratory.
Simultaneous in  situ multicomponent measurements 
next to high sensitivity and fast response time (ms to µs) 
are important requirements for breath analysis. Few spec-
troscopic techniques are able to fulfill these demands and a 
new promising candidate is the intracavity absorption spec-
troscopy (ICAS). Using a broadband tunable Tm/Ho-doped 
fiber laser (4780–5560 cm−1) and placing the sample inside 
the cavity, simultaneous detection of  H2O, 12CO2, 13CO2 and 
16O12C18O in breath was shown [119].
Furthermore, also broadband absorbing molecules, such 
as acetone [152], can be detected in breath samples with a 
portable and compact system. For example, Hancock et al. 
have demonstrated lab-based mid- and near-IR CEAS sys-
tems for breath acetone detection [98, 101]. Most recently, 
the same group have reported on a portable and compact 
device for measuring acetone in breath samples; the device 
features a 7 cm long high-finesse optical cavity that is cou-
pled to a miniature adsorption pre-concentrator containing 
0.5 g of polymer material [102]. Acetone is trapped out 
of breath and released into the optical cavity where it is 
Table 3  (continued)
Molecule λ (µm) Detection method Detection limit (measurement 
time)
Human tests/in vitro/application is 
breath, otherwise specified
Nitric oxide 5.23 ICOS + WMS 2 ppb (15 s) [136]
5.22 TDLAS + multipass cell 2 ppb (1 s) [137]
5.22 TDLAS + multipass cell 1.5 ppb (4 s) [138]
5.26 TDLAS + multipass cell 0.5 ppb (1 s) Asthma, COPD [34], Septic shock 
[139]
5.22 ICOS 0.4 ppb (1 s) [140]
5.2 ICOS 0.7 ppb (1 s) Breath and skin [141]
Nitric oxide (isotopes) 5.33 CRDS 7 ppt (70 s) [142]
5.43 Faraday rotation spectroscopy 0.5–4 ppb (1 s) Breath, blood, urine [143]
Nitrous oxide 4.57 TDLAS + multipass cell 0.8 ppb (1 s) Asthma, COPD [34]
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probed by a near-IR diode laser operating at ~ 1670 nm. 
With an optical cavity mirror reflectivity of 99.994%, a 
precision of 100 ppb is achieved with direct breath sam-
pling. The method was validated with measurements made 
using a chemical ionization mass spectrometer and meas-
urements on individuals under fasting, exercise, and nor-
mal conditions have been presented, indicating the utility 
of the device across a wide dynamic range. The device 
has a sufficiently small power requirement that battery 
operation is possible for a reasonable number of measure-
ments. This device has ready applicability for using breath 
acetone analysis to provide an alternative to blood testing 
for ketone measurement, to assist with the management of 
type 1 diabetes [153].
The fast development of the QCL combs, e.g., achiev-
ing higher power levels [154] and improvement in their 
frequency stability [155, 156] promises substantial 
improvements in the operation of QCL-based dual-comb 
spectrometers in the near future, making them more inter-
esting for biomedical applications.
It is well known that the time to market a device for medi-
cal purposes is longer than for other fields of applications. 
This might explain why some optical methods are not yet on 
the market, even though they have shown large potentials, as 
demonstrated by the examples presented here.
For detection of some compounds, such as  C2H4 or  NH3, 
optical methods are preferred over the MS-based ones, due 
to a better sensitivity, simplicity in operation and instrument 
price. Also, the ability of soft-ionization MS to detect light 
molecules is limited to those species with sufficient proton 
affinity. Notably,  NH3 cannot be sampled off-line, due to its 
“sticky” nature and interaction with surfaces of materials 
[107, 157].
Exhaled NO (or fractional exhaled NO in the gas phase, 
 FENO) is a well-known biomarker for airway inflammation 
[158], playing an important role in asthma phenotyping and 
management [159]. Moreover, its concentration is dependent 
on the exhalation flow (higher at low flow and vice versa). 
Studies showed that measuring NO at one flow rate, typi-
cally 50 ml/s, can neither determine the alveolar site/periph-
eral contribution, nor quantify the difference in NO diffusion 
from the airways walls. The use of NO modeling approach 
(linear or nonlinear) can solve this issue and provide useful 
information about the source of NO [2, 160]. There are still 
many unexplored areas for  FENO analysis and examining 
these will require the implementation of a sampling system 
allowing different flow rates into the measuring instrument. 
Different schemes using QCL have been already developed 
for  FENO and some are used in the clinical environment 
[34]. This will provide a great value in diagnostic procedures 
of respiratory diseases and in treatment with anti-inflam-
matory drugs by predicting the inhaled corticosteroid (ICS) 
response.
The sampling of exhaled breath is as important as its 
analysis [161, 162]. A careful selection of the laser source 
for spectroscopic measurements is usually required to limit 
spectral overlap with water and  CO2 which are quite abun-
dant in breath. However, whenever possible, it would actu-
ally be beneficial to monitor  CO2 simultaneously with the 
molecule of interest within the same scan [132, 133, 141]. 
A  CO2-controlled sampling of expiratory air allows a proper 
determination of the end-tidal metabolite concentration.
6.4  Threats
When broad band emission sources are used, such as EC-
QCL or OFC, the main challenge is to develop a robust 
algorithm that can discriminate between multiple absorb-
ing molecules using their specific spectroscopic features. 
Here, optical techniques will need to compete with other 
real-time MS-based techniques such as PTR-MS, SIFT-MS, 
and SESI-MS.
The latest incremental developments in MS-based tech-
nology seem to strengthen their market position. A repre-
sentative example is PTR-MS; although the instruments are 
not becoming cheaper, on the contrary, their features look 
potentially attractive for multispecies real-time monitoring. 
Over time, the PTR-MS instruments have been equipped 
with a time-of-flight (TOF) analyzer to improve the mass 
resolution and enable the analysis of compounds with almost 
the same molecular mass. The PTR-MS instruments have 
also been incorporated with additional reagent ions  (O2+, 
NO+, Kr + or Xe + in addition to standard  H3O+) which 
allow the ionization and detection of a larger variety of 
volatile compounds. Recently, a hexapole ion guide and a 
short chromatographic column (FastGC) are also available 
with the PTR-MS instruments. The main benefit of coupling 
a FastGC to a PTR-MS is that it allows the detection of 
isomers due to the chromatographic separation of the com-
pounds prior to entering the PTR-MS [163]. Furthermore, 
commercial PTR-MS instruments now include software that 
allows convenient data analysis of real-time measurements 
of breath profiles. This is of great importance since it aids 
in the identification of the different respiratory phases (dead 
space, end-tidal) by measuring the time-profiles of specific 
breath volatiles (e.g., acetone). The need for an elaborate 
breath sampler (incorporating a  CO2 analyzer, for example) 
can thus be circumvented by multispecies real-time analysis.
Other techniques are finding their way into breath analy-
sis; several clinical trials are presently ongoing with GC-
IMS and SESI-MS. The question is whether this could 
change the market beyond the ability of the optical tech-
niques to adapt and secure their position.
For detection of exhaled compounds in high concentration 
(ppm and above), such as methane, the electrochemical sen-
sors are highly competitive with the laser-based techniques, 
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especially that they are already commercially available from 
various vendors [164]. Furthermore, an ingestible electronic 
capsule based on semiconducting metal oxide-based sen-
sor has demonstrated its capability of sensing  O2,  H2 and 
 CO2 in the gut during a human pilot trial [165]. Using CRD 
technique with a Q-switched Nd:YAG laser at 266 nm, a 
standalone portable breath acetone analyzer was developed 
and tested on diabetic patients [166].
7  Current progress and challenges
With the technological developments been stimulated by 
the growing evidence of clinical worth, advanced research 
moved from measuring relevant molecules in laboratory to 
pilot studies in hospitals. The transition to clinical practice is 
in continuous progress; more commercial instruments found 
their way into clinics and reveal unprecedented information, 
with the few examples presented here. Like any other tech-
niques, to get into routine practice, the optical techniques 
need to overcome still several barriers at various levels from 
instrumental and scientific hurdles to regulatory approvals 
and financials [23, 27].
Breath sampling and measurement. At this stage, a lot 
of the practical problems regarding breath sampling and 
measurement have been identified and solutions are in place. 
This is still a crucial aspect for further implementation, not 
only for the optical techniques, but also for MS-based ones. 
Researchers became more aware of the importance of con-
trolling the exhalation rate and monitoring the exhaled  CO2 
in any accessible manner; most measurements are designed 
for acquisition of the alveolar air and elimination of the 
dead air space. No matter whether the measurements are 
online or offline, these set of parameters are the first steps 
towards standardization of breath sampling. Lessons have 
been learned by experience; therefore, rather than still being 
named a challenge, standardization includes a series of pro-
tocols that have been proposed and are currently tested for 
validation. For example, off-line collection (usually in Tedlar 
bags) requires a proper choice for the material and additional 
tests to check the cleanliness of the bags and the stability 
over time of the analyte of interest. For single or multiple 
exhalations, reproducibility of the breath samples needs to 
be also checked.
Instrumental challenge. Compact and user-friendly instru-
ments are highly desired, providing accurate measurements, 
preferably single time-point breath collection with high sen-
sitivity and specificity. They should monitor changes in bio-
marker concentrations or parameters compared to control or 
baseline values, etc. Therefore, calibration of the measuring 
system for determination of the gas concentration needs to 
be done taking into account the main compounds present in 
the matrix of breath, namely  H2O and  CO2 in air.
Scientific challenge and outcomes. Most of the com-
pounds that can be measured with the laser-based tech-
niques have known origin and biochemical pathways. 
Furthermore, understanding the connection biomarker-
disease-health conditions, and response of biomarker to 
interventions (exposure, isotope labeling, therapy, etc.) 
is crucial for integration into clinical practice. The high 
precision and absolute accuracy offered by the laser-based 
techniques allows collection of more data and in conse-
quence, very detailed biomarker studies. Small differences 
can be thus easier resolved, gas exchange in the respiratory 
tract can be characterized so that the origin and chemical 
pathways can be better understood. In turn, it will become 
more clear which biomarker reliably correlates with dis-
eases. Another aspect to be considered is that variability 
of the results may be strongly influenced by diet and life 
style and exposure to various environmental conditions.
Marketing and financial aspects. The success of a new 
breath test on the medical market depends on how well it 
is marketed to patients, physicians, heath institutions, and 
insurance companies.
8  Concluding remarks and future 
perspectives
Numerous laser spectroscopy methods have been developed 
in the laboratory during several decades and are reaching 
maturity. Their potential for medical analysis, in particular 
expired air, have been recognized early and numerous labo-
ratory demonstrations have been published. Today we are at 
a turning point, where techniques which have become widely 
used tools for the laser spectroscopists, can be promoted 
in new domains, in particular for medical applications. For 
that, it is necessary that researchers specialized in laser spec-
troscopy meet medical specialists to engage together in the 
instrumental development needed for their specific imple-
mentation (or application) in medical research. The rapidly 
increasing interest from the medical community, thanks to 
the recent promising findings in a wide range of (clinical) 
applications, is supporting breath analysis to become even 
more clinically available in the future, hopefully at least 
partly replacing current blood-based bioassays.
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